GITELMAN SYNDROME

✓ Medically ReviewedDISEASEID: MDBT0253🚨 TRIAGE: ROUTINEICD-10: N25.8

📖

Definition

CLINICAL DEFINITION

Gitelman syndrome is a rare, autosomal recessive renal tubulopathy characterised by hypokalaemic metabolic alkalosis, hypomagnesaemia, and hypocalciuria. It is caused by loss-of-function mutations in the SLC12A3 gene, which encodes the thiazide-sensitive sodium-chloride cotransporter (NCC) in the distal convoluted tubule.

IN PLAIN ENGLISH

Gitelman syndrome is a rare genetic kidney disorder where the kidneys fail to reabsorb salt properly, leading to low levels of potassium and magnesium in the blood. This can cause muscle weakness, cramps, and fatigue, and requires lifelong monitoring and electrolyte replacement.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Gitelman syndrome is NOT Bartter syndrome, although both cause hypokalaemic metabolic alkalosis; Gitelman syndrome is distinguished by hypomagnesaemia and hypocalciuria, whereas Bartter syndrome typically presents with hypercalciuria and normal serum magnesium. It is also NOT caused by diuretic abuse or chronic vomiting, which can mimic its biochemical profile.

🔤

Word Breakdown

Gitelman

=Eponym named after Hillel Gitelman, the American physician who first described the condition in 1966

syndrome

=A condition characterised by a specific set of clinical signs and symptoms (from Greek 'syndrome', the concurrence of symptoms)

Literal Meaning: A condition characterised by the concurrence of symptoms described by Gitelman

🏷️

Abbreviations

GS=Gitelman Syndrome — the standard clinical abbreviation

🔄

Synonyms & Variants

Familial Hypokalaemia-Hypomagnesaemia›Gitelman's Syndrome›Thiazide-like Tubulopathy›

🎯

Category-Specific Context

Gitelman syndrome is classified as a primary renal tubulopathy, specifically affecting the distal convoluted tubule. It falls within the spectrum of inherited salt-wasting tubulopathies, distinguished from other disorders like Bartter syndrome by its specific transporter defect and biochemical signature.

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Nephrology ClinicPaediatric EndocrinologyEmergency DepartmentGeneral Medicine Ward

USAGE & DOCUMENTATION NOTES

Clinicians typically refer to it as "GS" in ward round notes. The biochemical triad of hypokalaemia, hypomagnesaemia, and hypocalciuria is often documented as "GS profile" when evaluating unexplained electrolyte disturbances. Differentiation from surreptitious thiazide diuretic use is a frequent documentation point in adult presentations.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Gitelman syndrome results from inactivating mutations in the SLC12A3 gene, which encodes the thiazide-sensitive sodium-chloride cotransporter (NCC) located in the apical membrane of the distal convoluted tubule (DCT). Impaired NCC function reduces sodium and chloride reabsorption in the DCT, leading to mild volume depletion and secondary activation of the renin-angiotensin-aldosterone system (RAAS). Elevated aldosterone drives potassium and hydrogen ion secretion in the collecting duct, resulting in hypokalaemia and metabolic alkalosis. The defect in DCT sodium transport also enhances basolateral calcium reabsorption via the Na+/Ca2+ exchanger, causing hypocalciuria. Furthermore, down-regulation of the apical magnesium channel TRPM6 in the DCT leads to renal magnesium wasting and subsequent hypomagnesaemia.

PRIMARY CAUSES

SLC12A3 gene mutations

Autosomal recessive loss-of-function mutations impair the thiazide-sensitive Na-Cl cotransporter (NCC) in the distal convoluted tubule, mimicking chronic thiazide diuretic use.

Mitochondrial DNA mutations (rare)

Rare mitochondrial cytopathies can present with a Gitelman-like tubulopathy due to impaired energy-dependent tubular transport mechanisms.

🌍

Epidemiology

Prevalence:Estimated at 1 to 9 per 40,000 individuals in Western populations, though carrier frequency is approximately 1%. It is one of the most common inherited renal tubulopathies.

Age Group:Typically presents in late childhood, adolescence, or early adulthood. Unlike Bartter syndrome, it is rarely diagnosed in the neonatal period.

Sex Predilection:Equal

Geographic Distribution:Found globally, but certain founder mutations are prevalent in specific populations, such as the p.Gly741Arg mutation in the Roma population and specific SLC12A3 variants in East Asian cohorts.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 ROUTINE

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Unexplained hypokalaemia with normal blood pressure — requires evaluation for a renal tubulopathy or surreptitious diuretic abuse before attributing to poor intake.
Severe hypomagnesaemia in a young adult — raises concern for Gitelman syndrome and requires assessment for associated complications like chondrocalcinosis or cardiac arrhythmias.

URGENT EVALUATION TRIGGERS

Palpitations, syncope, or presyncope — requires immediate ECG to evaluate for QT prolongation or ventricular arrhythmias secondary to hypokalaemia/hypomagnesaemia.
Severe muscle weakness or paralysis — indicates profound hypokalaemia requiring urgent intravenous replacement and cardiac monitoring.
Tetany or seizures — suggests severe hypomagnesaemia or alkalosis requiring urgent correction.

Contraindications & Precautions

SPECIAL PRECAUTIONS

Avoid QT-prolonging medications due to the baseline risk of arrhythmias from hypokalaemia and hypomagnesaemia.
Monitor electrolytes closely during intercurrent illnesses (e.g.
gastroenteritis) that can exacerbate salt and fluid losses.
Counsel patients regarding the risks of dehydration during intense exercise or hot weather.

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Cardiac arrhythmias — secondary to severe hypokalaemia and hypomagnesaemia
potentially leading to prolonged QT interval
Chondrocalcinosis (pseudogout) — associated with chronic hypomagnesaemia
Growth retardation — observed in some paediatric cases with severe
uncorrected electrolyte deficits
Rhabdomyolysis — triggered by profound hypokalaemia during periods of physical stress

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Bartter Syndrome

Both are inherited hypokalaemic metabolic alkalosis tubulopathies. Bartter affects the thick ascending limb (loop diuretic-like) with hypercalciuria, whereas Gitelman affects the distal convoluted tubule (thiazide-like) with hypocalciuria.

Liddle Syndrome

Both are genetic tubulopathies affecting potassium handling, but Liddle syndrome causes hypertension and hypokalaemia due to ENaC overactivity, unlike the normotensive Gitelman syndrome.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Surreptitious Thiazide Diuretic Use

Key Distinguishing Feature: Biochemically identical to Gitelman syndrome; distinguished by a negative genetic test and positive urine screen for thiazide diuretics.

Chronic Vomiting / Bulimia Nervosa

Key Distinguishing Feature: Causes hypokalaemic metabolic alkalosis but presents with low urine chloride (< 20 mmol/L), whereas Gitelman syndrome has high urine chloride.

Bartter Syndrome

Key Distinguishing Feature: Typically presents earlier in life with hypercalciuria and normal serum magnesium, unlike the hypocalciuria and hypomagnesaemia of Gitelman syndrome.

Primary Hyperaldosteronism

Key Distinguishing Feature: Presents with hypertension and suppressed renin, whereas Gitelman syndrome features normotension and elevated renin.

💎

Clinical Pearls

💎

The biochemical profile of Gitelman syndrome perfectly mimics chronic thiazide diuretic use; always rule out surreptitious diuretic abuse in adults presenting with this triad before ordering genetic testing.

💎

Unlike Bartter syndrome, which typically presents in infancy with failure to thrive, Gitelman syndrome is often asymptomatic or mildly symptomatic and frequently diagnosed incidentally on routine blood tests in adolescents or adults.

💎

Hypomagnesaemia in Gitelman syndrome is often refractory to oral magnesium supplementation alone; combining magnesium salts with potassium-sparing diuretics (e.g., amiloride) can improve retention of both electrolytes.

💎

Chondrocalcinosis (pseudogout) is a unique, late complication of chronic hypomagnesaemia in Gitelman syndrome and should be considered in patients presenting with acute monoarthritis.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"A 24-year-old male presented with fatigue and muscle cramps; investigations revealed hypokalaemic metabolic alkalosis, hypomagnesaemia, and hypocalciuria, consistent with Gitelman syndrome."

IN A SOAP NOTE

S: 19-year-old female reports intermittent muscle cramps and fatigue over the past 3 months. No vomiting or diarrhoea. O: BP 110/70 mmHg. HR 78 bpm. Normal power in all limbs. Serum K+ 2.8 mmol/L, Mg2+ 0.4 mmol/L. Venous blood gas shows pH 7.48, HCO3- 32 mmol/L. Urine calcium:creatinine ratio is low. A: Hypokalaemic metabolic alkalosis with hypomagnesaemia and hypocalciuria. Highly suspicious for Gitelman syndrome; differential includes surreptitious thiazide use. P: Send urine toxicology screen for diuretics. Arrange SLC12A3 genetic testing. Commence oral potassium chloride slow-release and magnesium oxide. ECG to check QT interval.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for hypokalaemic metabolic alkalosis with normal blood pressure: (1) Gitelman syndrome (hypomagnesaemia, hypocalciuria, high urine chloride); (2) Bartter syndrome (hypercalciuria, usually presents in childhood); (3) Surreptitious thiazide diuretic use (biochemically identical to Gitelman, requires urine drug screen); (4) Surreptitious vomiting (low urine chloride < 20 mmol/L).

📈

Prognosis

SHORT-TERM OUTCOME

With appropriate electrolyte supplementation, acute symptoms such as muscle cramps and tetany resolve rapidly. Life-threatening arrhythmias are rare if potassium and magnesium are corrected.

LONG-TERM PROGNOSIS

Generally excellent life expectancy and normal renal function in the long term. However, patients require lifelong electrolyte monitoring and replacement, and some may experience chronic fatigue or reduced quality of life.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

N25.8

LITERATURE CITATIONS & GUIDELINES

[1]Knoers NVAM, Levchenko EN. Gitelman Syndrome. In: Adam MP, et al., editors. GeneReviews. Seattle: University of Washington; 2023.

[2]Simon DB, et al. Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive Na-Cl cotransporter. Nat Genet. 1996;14(2):152-156.

[3]Blanchard A, et al. Gitelman syndrome. Orphanet J Rare Dis. 2004;...

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.